News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Charles Jiang: A visualization tool for adjuvant therapy risks and benefits discussion
Charles Jiang/utswmed.org
Feb 11, 2025, 10:21

Charles Jiang: A visualization tool for adjuvant therapy risks and benefits discussion

Charles Jiang, Medical Oncologist at UT Southwestern, shared a post on X

“Fellow oncologists – check out my free visualization tool for adjuvant therapy risks and benefits discussion.

It’s built for clarity and is so HIPPA compliant you don’t even have a place to enter HIPPA info. Try it here.”

Charles Jiang: A visualization tool for adjuvant therapy risks and benefits discussion

More posts featuring Charles Jiang.

Adjuvant Therapy cancer Charles Jiang OncoDaily Oncology risks and benefits
Special Coverage
Career
Jun 26, 2025, 18:06
Penn State Health Children's Hospital Is Seeking a Director for the Solid Tumor Program
Insight
Jun 26, 2025, 17:54
E. Shyam P. Reddy: Obesity Drugs Might also Tackle Migraine
Opinion
Jun 26, 2025, 17:47
MASCC 2025 Highlights: Global Crisis of Financial Toxicity in Cancer Care
Opinion
Jun 26, 2025, 17:46
MASCC 2025 Highlights BVGH’s Global Solutions to Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:45
MASCC 2025 Highlights: Addressing Financial Toxicity in Cancer Supportive Care
Science
Jun 26, 2025, 17:29
Myeloma Paper of the Day, June 26th, Suggested by Robert Orlowski
Oncolibrary
Jun 26, 2025, 14:50
What Is a Chemotherapy Port? Uses, Benefits and Complications
OncoDaily Pulse
Jun 26, 2025, 14:45
Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night
Blog
Jun 26, 2025, 14:20
Sendurai Mani: Gratitude and Great Science at our Lab Retreat
Oncolibrary
Jun 26, 2025, 14:14
MASCC 2025 Highlights: MuReva OM Dramatically Reduces Severe Oral Mucositis in HNC
Oncolibrary
Jun 26, 2025, 14:12
MASCC 2025 Highlights: Key Toxicity Findings in ADC-Treated Cancer Patients
Blog
Jun 26, 2025, 14:05
Mieke Van Hemelrijck Joined EORTC Board and General Assembly Meetings 2025 in Brussels